The Centre has urged states and union territories to focus on beneficiaries who are awaiting their second dose of vaccine as per the schedu...

An expert panel of the Central drug authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children...

Out of these vessels, three Steel catamaran vessels, namely MV Lohitwill ply between Nimatighat and Kamalabari, MV Sonai from Guwahati to K...

Indian banks face systemic risk as the country sorts through the aftermath of the COVID second wave. Lenders struggled with a high level of...

Bharat Biotech had issued a statement saying, “Capacity expansion has been implemented across multiple facilities... to reach 700 million d...

There are no two opinions that the way out of the pandemic still remains the same – express vaccination till we achieve herd immunity. Isra...

Several Asian countries scrambled to find alternative sources for COVID-19 inoculations on Tuesday after export restrictions by manufacture...

A notice issued to the foreign journalists here on Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's...

One group of suspects made a profit of about 18 million yuan ($2.8 million) by packaging saline solution or mineral water in 58,000 doses o...

COVAX, a global scheme co-led by the WHO, wants to deliver at least 2 billion COVID-19 doses across the world this year, with at least 1.3 ...

China in late December approved its first vaccine for general public use. Three vaccines had already been given to limited groups at high r...

All India Bank Officers' Confederation (AIBOC), All India Bank Officers' Association (AIBOA), Indian National Bank Officers' Congress (INBO...

Speaking at the India Mobile Congress, he said mobile technology has enabled benefits worth billions of dollars to reach the deserving and ...

Although India experienced one of the largest growth contractions among emerging markets in 2020, the larger decline sets stage for a large...

Pfizer, with partner BioNTech SE, and rival Moderna have released trial data showing their COVID-19 vaccines to be about 95% effective at p...

Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in...

The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov 23 the positive late-state trial result of the c...